Skin | |||||
---|---|---|---|---|---|
Skin / Hyperhidrosis | |||||
aluminium chloride hexahydrate | NON-FORMULARY | ||||
Liquid | |||||
Anhydrol (Dermal Laboratories Ltd) | NON-FORMULARY | ||||
botulinum toxin type A | HOSPITAL ONLY PRESCRIBING |
NICE TA260 NICE TA605 |
|||
Powder for solution for injection | |||||
Azzalure (Galderma (UK) Ltd) | HOSPITAL ONLY PRESCRIBING | ||||
Bocouture (Merz Pharma UK Ltd) | HOSPITAL ONLY PRESCRIBING | ||||
Botox (AbbVie Ltd) | HOSPITAL ONLY PRESCRIBING | ||||
Dysport (Ipsen Ltd) | HOSPITAL ONLY PRESCRIBING | ||||
Xeomin (Merz Pharma UK Ltd) | HOSPITAL ONLY PRESCRIBING | ||||
glycopyrronium bromide | NON-FORMULARY | ||||
Skin / Scalp and hair conditions | |||||
benzalkonium chloride | NON-FORMULARY | ||||
Shampoo | |||||
Dermax (Dermal Laboratories Ltd) | NON-FORMULARY | ||||
NHSE OTC dandruff
NHS England Guidance for CCGs on prescribing OTC products (Mar-18):
General exceptions listed in guidance include long-term conditions; complex illness; patient group not licensed for OTC product; exceptional circumstances based on clinician’s judgement. See guidance for full list. |
|||||
cetrimide with undecenoic acid | FORMULARY PRODUCT | ||||
coal tar | SPECIALIST INITIATED- Primary care to continue with no Shared Care Guidelines | ||||
Shampoo | |||||
Coal tar (Non-proprietary) | SPECIALIST INITIATED- Primary care to continue with no Shared Care Guidelines | ||||
COAL TAR PRODUCTS FORMULARY STATUS
Coal tar containing products are established treatment options used in dermatology endorsed by NICE CKS Click here Please note, Coal Tar products should not be routinely prescribed for minor dermatological conditions - patients should be encouraged self-care and to buy over the counter, where appropriate. Coal Tar products can be prescribed as formulary treatment options for moderate-severe cases. |
|||||
Neutrogena T/Gel Therapeutic (Johnson & Johnson Ltd) | NON-FORMULARY | ||||
NHSE OTC dandruff
NHS England Guidance for CCGs on prescribing OTC products (Mar-18):
General exceptions listed in guidance include long-term conditions; complex illness; patient group not licensed for OTC product; exceptional circumstances based on clinician’s judgement. See guidance for full list. |
|||||
Polytar Scalp (Thornton & Ross Ltd) | FORMULARY PRODUCT | ||||
NHSE OTC dandruff
NHS England Guidance for CCGs on prescribing OTC products (Mar-18):
General exceptions listed in guidance include long-term conditions; complex illness; patient group not licensed for OTC product; exceptional circumstances based on clinician’s judgement. See guidance for full list. |
|||||
Cutaneous emulsion | |||||
Exorex (Teva UK Ltd) | NON-FORMULARY | ||||
ketoconazole | NON-FORMULARY | ||||
Shampoo | |||||
Ketoconazole (Non-proprietary) | NON-FORMULARY | ||||
NHSE OTC dandruff
NHS England Guidance for CCGs on prescribing OTC products (Mar-18):
General exceptions listed in guidance include long-term conditions; complex illness; patient group not licensed for OTC product; exceptional circumstances based on clinician’s judgement. See guidance for full list. |
|||||
Dandrazol (Transdermal Ltd) | NON-FORMULARY | ||||
NHSE OTC dandruff
NHS England Guidance for CCGs on prescribing OTC products (Mar-18):
General exceptions listed in guidance include long-term conditions; complex illness; patient group not licensed for OTC product; exceptional circumstances based on clinician’s judgement. See guidance for full list. |
|||||
Nizoral (Thornton & Ross Ltd) | NON-FORMULARY | ||||
NHSE OTC dandruff
NHS England Guidance for CCGs on prescribing OTC products (Mar-18):
General exceptions listed in guidance include long-term conditions; complex illness; patient group not licensed for OTC product; exceptional circumstances based on clinician’s judgement. See guidance for full list. |
|||||
selenium | NON-FORMULARY | ||||
Skin / Alopecia | |||||
finasteride | NON-FORMULARY | ||||
minoxidil | NON-FORMULARY | ||||
Liquid | |||||
Minoxidil (Non-proprietary) | NON-FORMULARY | ||||
Regaine (Johnson & Johnson Ltd, McNeil Products Ltd) | NON-FORMULARY | ||||
Skin / Hirsutism | |||||
co-cyprindiol | SPECIALIST INITIATED- Primary care to continue with no Shared Care Guidelines | ||||
eflornithine | SPECIALIST INITIATED- Primary care to continue with no Shared Care Guidelines | ||||
Skin / Superficial soft-tissue injuries and superficial thrombophlebitis | |||||
heparinoid | NON-FORMULARY | ||||
Skin / Dry and scaling skin disorders | |||||
barrier creams and ointments | FORMULARY PRODUCT | ||||
NHSE OTC- Mild dry skin
NHS England guidance for CCGs on prescribing of OTC products (Mar-18):
General exceptions listed in guidance include long-term conditions; complex illness; patient group not licensed for OTC product; exceptional circumstances based on clinician’s judgement. See guidance for full list. |
|||||
emollient bath and shower products, antimicrobial-containing | NON-FORMULARY | ||||
NHSE OTC- Mild dry skin
NHS England guidance for CCGs on prescribing of OTC products (Mar-18):
General exceptions listed in guidance include long-term conditions; complex illness; patient group not licensed for OTC product; exceptional circumstances based on clinician’s judgement. See guidance for full list. |
|||||
Bath additive | |||||
Dermol 600 (Dermal Laboratories Ltd) | NON-FORMULARY | ||||
NHSE OTC- Mild dry skin
NHS England guidance for CCGs on prescribing of OTC products (Mar-18):
General exceptions listed in guidance include long-term conditions; complex illness; patient group not licensed for OTC product; exceptional circumstances based on clinician’s judgement. See guidance for full list. |
|||||
Emulsiderm (Dermal Laboratories Ltd) | NON-FORMULARY | ||||
NHSE OTC- Mild dry skin
NHS England guidance for CCGs on prescribing of OTC products (Mar-18):
General exceptions listed in guidance include long-term conditions; complex illness; patient group not licensed for OTC product; exceptional circumstances based on clinician’s judgement. See guidance for full list. |
|||||
Oilatum Plus (Thornton & Ross Ltd) | NON-FORMULARY | ||||
NHSE OTC- Mild dry skin
NHS England guidance for CCGs on prescribing of OTC products (Mar-18):
General exceptions listed in guidance include long-term conditions; complex illness; patient group not licensed for OTC product; exceptional circumstances based on clinician’s judgement. See guidance for full list. |
|||||
emollient bath and shower products, paraffin-containing | |||||
NHSE OTC- Mild dry skin
NHS England guidance for CCGs on prescribing of OTC products (Mar-18):
General exceptions listed in guidance include long-term conditions; complex illness; patient group not licensed for OTC product; exceptional circumstances based on clinician’s judgement. See guidance for full list. |
|||||
Bath additive | |||||
Emollient bath and shower products, paraffin-containing (Non-proprietary) | NON-FORMULARY | ||||
NHSE OTC- Mild dry skin
NHS England guidance for CCGs on prescribing of OTC products (Mar-18):
General exceptions listed in guidance include long-term conditions; complex illness; patient group not licensed for OTC product; exceptional circumstances based on clinician’s judgement. See guidance for full list. |
|||||
Dermalo (Dermal Laboratories Ltd) | FIRST-LINE FORMULARY PRODUCT | ||||
NHSE OTC- Mild dry skin
NHS England guidance for CCGs on prescribing of OTC products (Mar-18):
General exceptions listed in guidance include long-term conditions; complex illness; patient group not licensed for OTC product; exceptional circumstances based on clinician’s judgement. See guidance for full list. |
|||||
Zerolatum (Thornton & Ross Ltd) | NON-FORMULARY | ||||
NHSE OTC- Mild dry skin
NHS England guidance for CCGs on prescribing of OTC products (Mar-18):
General exceptions listed in guidance include long-term conditions; complex illness; patient group not licensed for OTC product; exceptional circumstances based on clinician’s judgement. See guidance for full list. |
|||||
Cutaneous wash | |||||
Emollient bath and shower products, paraffin-containing (Non-proprietary) | NON-FORMULARY | ||||
NHSE OTC- Mild dry skin
NHS England guidance for CCGs on prescribing of OTC products (Mar-18):
General exceptions listed in guidance include long-term conditions; complex illness; patient group not licensed for OTC product; exceptional circumstances based on clinician’s judgement. See guidance for full list. |
|||||
E45 emollient wash (Karo Pharma UK Ltd) | NON-FORMULARY | ||||
NHSE OTC- Mild dry skin
NHS England guidance for CCGs on prescribing of OTC products (Mar-18):
General exceptions listed in guidance include long-term conditions; complex illness; patient group not licensed for OTC product; exceptional circumstances based on clinician’s judgement. See guidance for full list. |
|||||
emollient bath and shower products, soya-bean oil-containing | |||||
NHSE OTC- Mild dry skin
NHS England guidance for CCGs on prescribing of OTC products (Mar-18):
General exceptions listed in guidance include long-term conditions; complex illness; patient group not licensed for OTC product; exceptional circumstances based on clinician’s judgement. See guidance for full list. |
|||||
Bath additive | |||||
Zeroneum (Thornton & Ross Ltd) | NON-FORMULARY | ||||
NHSE OTC- Mild dry skin
NHS England guidance for CCGs on prescribing of OTC products (Mar-18):
General exceptions listed in guidance include long-term conditions; complex illness; patient group not licensed for OTC product; exceptional circumstances based on clinician’s judgement. See guidance for full list. |
|||||
emollient creams and ointments, colloidal oatmeal-containing | |||||
NHSE OTC- Mild dry skin
NHS England guidance for CCGs on prescribing of OTC products (Mar-18):
General exceptions listed in guidance include long-term conditions; complex illness; patient group not licensed for OTC product; exceptional circumstances based on clinician’s judgement. See guidance for full list. |
|||||
Form unstated | |||||
Emollient creams and ointments, colloidal oatmeal-containing (Non-proprietary) | NON-FORMULARY | ||||
NHSE OTC- Mild dry skin
NHS England guidance for CCGs on prescribing of OTC products (Mar-18):
General exceptions listed in guidance include long-term conditions; complex illness; patient group not licensed for OTC product; exceptional circumstances based on clinician’s judgement. See guidance for full list. |
|||||
emollient creams and ointments, paraffin-containing | |||||
NHSE OTC- Mild dry skin
NHS England guidance for CCGs on prescribing of OTC products (Mar-18):
General exceptions listed in guidance include long-term conditions; complex illness; patient group not licensed for OTC product; exceptional circumstances based on clinician’s judgement. See guidance for full list. |
|||||
Spray | |||||
Emollin (C D Medical Ltd) | NON-FORMULARY | ||||
NHSE OTC- Mild dry skin
NHS England guidance for CCGs on prescribing of OTC products (Mar-18):
General exceptions listed in guidance include long-term conditions; complex illness; patient group not licensed for OTC product; exceptional circumstances based on clinician’s judgement. See guidance for full list. |
|||||
emollients, urea-containing | FORMULARY PRODUCT | ||||
Formulary choices for urea-containing products
First line formulary choices are as follows:
Second line formulary choices are as follows:
Non-formulary: Flexitol
Further information:
MHRA DRUG SAFETY UPDATE: Risk of severe and fatal burns with emollients, data suggest there is also a risk for paraffin-free emollients. click here |
|||||
Emollient Guidelines
The emollient guidelines were developed in collaboration with Medicines Management, Consultant Dermatologists and General Practitioners with specialist interest in dermatology. |
|||||
NHSE OTC- Mild dry skin
NHS England guidance for CCGs on prescribing of OTC products (Mar-18):
General exceptions listed in guidance include long-term conditions; complex illness; patient group not licensed for OTC product; exceptional circumstances based on clinician’s judgement. See guidance for full list. |
|||||
Products without form | |||||
Emollients, urea-containing (Non-proprietary) | FORMULARY PRODUCT | ||||
NHSE OTC- Mild dry skin
NHS England guidance for CCGs on prescribing of OTC products (Mar-18):
General exceptions listed in guidance include long-term conditions; complex illness; patient group not licensed for OTC product; exceptional circumstances based on clinician’s judgement. See guidance for full list. |
|||||
Dermatonics Once (Dermatonics Ltd) | FORMULARY PRODUCT | ||||
NHSE OTC- Mild dry skin
NHS England guidance for CCGs on prescribing of OTC products (Mar-18):
General exceptions listed in guidance include long-term conditions; complex illness; patient group not licensed for OTC product; exceptional circumstances based on clinician’s judgement. See guidance for full list. |
|||||
Flexitol (Thornton & Ross Ltd) | NON-FORMULARY | ||||
NHSE OTC- Mild dry skin
NHS England guidance for CCGs on prescribing of OTC products (Mar-18):
General exceptions listed in guidance include long-term conditions; complex illness; patient group not licensed for OTC product; exceptional circumstances based on clinician’s judgement. See guidance for full list. |
|||||
Skin / Acne | |||||
adapalene | FORMULARY PRODUCT | ||||
azelaic acid | FORMULARY PRODUCT | ||||
benzoyl peroxide | FORMULARY PRODUCT | ||||
clindamycin | SPECIALIST INITIATED- Primary care to continue with no Shared Care Guidelines | ||||
CLINDAMYCIN
PARENTERAL FORMULATION IS FOR HOSPITAL PRESCRIBING ONLY |
|||||
Solution for injection | |||||
Clindamycin (Non-proprietary) | HOSPITAL ONLY PRESCRIBING | ||||
Dalacin C (Pfizer Ltd) | HOSPITAL ONLY PRESCRIBING | ||||
co-cyprindiol | SPECIALIST INITIATED- Primary care to continue with no Shared Care Guidelines | ||||
doxycycline | FORMULARY PRODUCT | ||||
Modified-release capsule | |||||
Efracea (Galderma (UK) Ltd) | NON-FORMULARY | ||||
erythromycin | |||||
Powder for solution for infusion | |||||
Erythromycin (Non-proprietary) | HOSPITAL ONLY PRESCRIBING | ||||
isotretinoin | HOSPITAL ONLY PRESCRIBING | ||||
minocycline | HOSPITAL ONLY PRESCRIBING | ||||
HOSPITAL USE
HOSPITAL ONLY for all indications |
|||||
Modified-release capsule | |||||
Acnamino MR (Dexcel-Pharma Ltd) | HOSPITAL ONLY PRESCRIBING | ||||
Minocin MR (Viatris UK Healthcare Ltd) | HOSPITAL ONLY PRESCRIBING | ||||
nicotinamide | NON-FORMULARY | ||||
Skin / Rosacea | |||||
azelaic acid | FORMULARY PRODUCT | ||||
ivermectin | FORMULARY PRODUCT | ||||
Skin / Sun protection and photodamage | |||||
fluorouracil | HOSPITAL ONLY PRESCRIBING | ||||
FORMULARY STATUS FOR SKIN KERATOSES, BOWEN'S DISEASE AND BASAL CELL CARCINOMA
Topical 5-Fluorouracil (5-FU) cream is SHARED CARE for Skin Keratoses, Bowen’s Disease and basal cell carcinoma. It can be prescribed in primary care under shared care following initiation from specialist. |
|||||
Solution for injection | |||||
Fluorouracil (Non-proprietary) | HOSPITAL ONLY PRESCRIBING | ||||
Solution for infusion | |||||
Fluorouracil (Non-proprietary) | HOSPITAL ONLY PRESCRIBING | ||||
ingenol mebutate | NON-FORMULARY | ||||
Skin / Warts and calluses | |||||
formaldehyde | NON-FORMULARY | ||||
Liquid | |||||
Formaldehyde (Non-proprietary) | NON-FORMULARY | ||||
imiquimod | SPECIALIST INITIATED- Primary care to continue with Shared Care Guidelines | ||||
A formal Shared Care Guideline (SCG) may be available.
If it is for the specific condition you are asked to continue treatment for and you are happy to prescribe in accordance with the guideline, then take over the agreed responsibilities including prescribing. Please ensure the document is scanned into the patient's electronic records. |
|||||
podophyllotoxin | NON-FORMULARY | ||||
Liquid | |||||
Warticon (Phoenix Labs Ltd) | NON-FORMULARY | ||||
salicylic acid | NON-FORMULARY | ||||
NHSE OTC Warts and Varrucas
NHS England Guidance for CCGs on prescribing of OTC products (Mar-18):
|
|||||
Liquid | |||||
Occlusal (Alliance Pharmaceuticals Ltd) | NON-FORMULARY | ||||
NHSE OTC Warts and Varrucas
NHS England Guidance for CCGs on prescribing of OTC products (Mar-18):
|
|||||
silver nitrate | HOSPITAL ONLY PRESCRIBING | ||||
Stick | |||||
Avoca (Bray Group Ltd) | HOSPITAL ONLY PRESCRIBING | ||||
Skin / Eczema and psoriasis | |||||
abrocitinib | HOSPITAL ONLY PRESCRIBING |
NICE TA814 |
|||
acitretin | HOSPITAL ONLY PRESCRIBING | ||||
adalimumab | HOSPITAL ONLY PRESCRIBING |
NICE TA187 NICE TA329 NICE TA199 NICE TA195 NICE TA375 NICE TA715 NICE TA383 NICE TA392 NICE TA146 NICE TA460 |
|||
Solution for injection | |||||
Humira (AbbVie Ltd) | HOSPITAL ONLY PRESCRIBING | ||||
alclometasone dipropionate | NON-FORMULARY | ||||
alitretinoin | HOSPITAL ONLY PRESCRIBING |
NICE TA177 |
|||
apremilast | HOSPITAL ONLY PRESCRIBING |
NICE TA433 NICE TA419 |
|||
azathioprine | SPECIALIST INITIATED- Primary care to continue with Shared Care Guidelines | ||||
AZATHIOPRINE - HOSPITAL ONLY INDICATIONS
Azathioprine is HOSPITAL ONLY for SEVERE ATOPIC DERMATITIS and RENAL TRANSPLANTATION |
|||||
baricitinib | HOSPITAL ONLY PRESCRIBING |
NICE TA466 NICE TA681 NICE TA926 |
|||
beclometasone dipropionate | FORMULARY PRODUCT | ||||
betamethasone | FORMULARY PRODUCT | ||||
Liquid | |||||
Betacap (Dermal Laboratories Ltd) | FORMULARY PRODUCT | ||||
Betnovate (GlaxoSmithKline UK Ltd) | FORMULARY PRODUCT | ||||
Diprosone (Organon Pharma (UK) Ltd) | NON-FORMULARY | ||||
Medicated plaster | |||||
Betesil (Derma UK Ltd) | SPECIALIST INITIATED- Primary care to continue with no Shared Care Guidelines | ||||
Betesil medicated plaster for Chronically scratched areas of the skin which causes inflammation and thickening of the epidermis.
GP can prescribe on the recommendation of a GPSI or dermatologist. Suitable for chronic plaque psoriasis localized in difficult to treat areas (e.g. knees, elbows and anterior face of the tibia on an area not greater than 5% of the body surface). Condition for approval: Barts Health to produce a one-page pathway/ prescribing guide to aid clinicians prescribing in primary care (will include flowchart/ treatment pathway/referral details). |
|||||
betamethasone with clioquinol | NON-FORMULARY | ||||
betamethasone with fusidic acid | FORMULARY PRODUCT | ||||
betamethasone with neomycin | NON-FORMULARY | ||||
calcipotriol | FORMULARY PRODUCT | ||||
Liquid | |||||
Calcipotriol (Non-proprietary) | FORMULARY PRODUCT | ||||
calcitriol | NON-FORMULARY | ||||
Oral solution | |||||
Calcitriol (Non-proprietary) | NON-FORMULARY | ||||
ciclosporin | SPECIALIST INITIATED- Primary care to continue with Shared Care Guidelines |
NICE TA369 |
|||
CICLOSPORIN (NEORAL)
Ciclosporin (Neoral) is HOSPITAL ONLY for renal transplant patients and severe resistant childhood psoriasis and atopic eczema |
|||||
Oral solution | |||||
Neoral (Novartis Pharmaceuticals UK Ltd) | SPECIALIST INITIATED- Primary care to continue with Shared Care Guidelines | ||||
Sandimmun (Novartis Pharmaceuticals UK Ltd) | SPECIALIST INITIATED- Primary care to continue with Shared Care Guidelines | ||||
Solution for infusion | |||||
Sandimmun (Novartis Pharmaceuticals UK Ltd) | HOSPITAL ONLY PRESCRIBING | ||||
clobetasol propionate | FORMULARY PRODUCT | ||||
Liquid | |||||
Dermovate (GlaxoSmithKline UK Ltd) | FORMULARY PRODUCT | ||||
Shampoo | |||||
Etrivex (Galderma (UK) Ltd) | NON-FORMULARY | ||||
clobetasone butyrate | FORMULARY PRODUCT | ||||
coal tar | SPECIALIST INITIATED- Primary care to continue with no Shared Care Guidelines | ||||
Shampoo | |||||
Coal tar (Non-proprietary) | SPECIALIST INITIATED- Primary care to continue with no Shared Care Guidelines | ||||
COAL TAR PRODUCTS FORMULARY STATUS
Coal tar containing products are established treatment options used in dermatology endorsed by NICE CKS Click here Please note, Coal Tar products should not be routinely prescribed for minor dermatological conditions - patients should be encouraged self-care and to buy over the counter, where appropriate. Coal Tar products can be prescribed as formulary treatment options for moderate-severe cases. |
|||||
Neutrogena T/Gel Therapeutic (Johnson & Johnson Ltd) | NON-FORMULARY | ||||
Polytar Scalp (Thornton & Ross Ltd) | FORMULARY PRODUCT | ||||
Cutaneous emulsion | |||||
Exorex (Teva UK Ltd) | NON-FORMULARY | ||||
coal tar with calamine | SPECIALIST INITIATED- Primary care to continue with no Shared Care Guidelines | ||||
coal tar with coconut oil and salicylic acid | FORMULARY PRODUCT | ||||
coal tar with salicylic acid | SPECIALIST INITIATED- Primary care to continue with no Shared Care Guidelines | ||||
coal tar with zinc oxide | SPECIALIST INITIATED- Primary care to continue with no Shared Care Guidelines | ||||
dimethyl fumarate | HOSPITAL ONLY PRESCRIBING | ||||
Skilarence® NICE TA475 Tecfidera® NICE TA320 |
|||||
Gastro-resistant tablet | |||||
Skilarence (Almirall Ltd) | HOSPITAL ONLY PRESCRIBING | ||||
Gastro-resistant capsule | |||||
Tecfidera (Biogen Idec Ltd) | HOSPITAL ONLY PRESCRIBING | ||||
dithranol | SPECIALIST INITIATED- Primary care to continue with no Shared Care Guidelines | ||||
British Association of Dermatologists (BAD) list of preferred Specials
For many common dermatological diseases including psoriasis and eczema, the range of licensed medicines is limited. |
|||||
etanercept | HOSPITAL ONLY PRESCRIBING |
NICE TA103 NICE TA195 NICE TA375 NICE TA715 NICE TA199 NICE TA383 |
|||
Solution for injection | |||||
Benepali (Biogen Idec Ltd) | HOSPITAL ONLY PRESCRIBING | ||||
Enbrel (Pfizer Ltd) | HOSPITAL ONLY PRESCRIBING | ||||
Enbrel MyClic (Pfizer Ltd) | HOSPITAL ONLY PRESCRIBING | ||||
Erelzi (Sandoz Ltd) | HOSPITAL ONLY PRESCRIBING | ||||
Powder and solvent for solution for injection | |||||
Enbrel (Pfizer Ltd) | HOSPITAL ONLY PRESCRIBING | ||||
fludroxycortide | NON-FORMULARY | ||||
Impregnated dressing | |||||
Fludroxycortide (Non-proprietary) | NON-FORMULARY | ||||
fluocinolone acetonide | FORMULARY PRODUCT |
NICE TA301 NICE TA613 NICE TA590 |
|||
fluocinonide | NON-FORMULARY | ||||
fluticasone | FORMULARY PRODUCT | ||||
hydrocortisone | FORMULARY PRODUCT | ||||
Solution for injection | |||||
Hydrocortisone (Non-proprietary) | HOSPITAL ONLY PRESCRIBING | ||||
hydrocortisone butyrate | NON-FORMULARY | ||||
Liquid | |||||
Locoid (Neon Healthcare Ltd) | NON-FORMULARY | ||||
ichthammol | SPECIALIST INITIATED- Primary care to continue with no Shared Care Guidelines | ||||
British Association of Dermatologists (BAD) list of preferred Specials
For many common dermatological diseases including psoriasis and eczema, the range of licensed medicines is limited. |
|||||
infliximab | HOSPITAL ONLY PRESCRIBING |
NICE TA134 NICE TA195 NICE TA375 NICE TA715 NICE TA199 NICE TA187 NICE TA163 NICE TA329 NICE TA383 |
|||
methotrexate | SPECIALIST INITIATED- Primary care to continue with Shared Care Guidelines | ||||
METHOTREXATE FOR ARTHRITIS IN CHILDREN
Methotrexate is HOSPITAL ONLY for arthritis in children. Injection formulations are HOSPITAL ONLY. |
|||||
Shared Care Guideline
If it is for the specific condition you are asked to continue treatment for and you are happy to prescribe in accordance with the guideline, then take over the agreed responsibilities including prescribing. Please ensure the document is scanned into the patient's electronic records. Click here for the Shared Care Guideline Repository If sufficient information has not been provided and if you do not feel happy to continue to prescribe, it is advisable to refer the patient back to the specialist clinic and complete and send as soon as possible an 'inappropriate prescribing request communication form' .
|
|||||
Shared Care Guideline
If it is for the specific condition you are asked to continue treatment for and you are happy to prescribe in accordance with the guideline, then take over the agreed responsibilities including prescribing. Please ensure the document is scanned into the patient's electronic records. Click here for the Shared Care Guideline Repository If sufficient information has not been provided and if you do not feel happy to continue to prescribe, it is advisable to refer the patient back to the specialist clinic and complete and send as soon as possible an 'inappropriate prescribing request communication form' .
|
|||||
Oral solution | |||||
Methotrexate (Non-proprietary) | SPECIALIST INITIATED- Primary care to continue with Shared Care Guidelines | ||||
Solution for injection | |||||
Methotrexate (Non-proprietary) | HOSPITAL ONLY PRESCRIBING | ||||
Methofill (Accord-UK Ltd) | HOSPITAL ONLY PRESCRIBING | ||||
Metoject PEN (medac UK) | HOSPITAL ONLY PRESCRIBING | ||||
Nordimet (Nordic Pharma Ltd) | HOSPITAL ONLY PRESCRIBING | ||||
Zlatal (Nordic Pharma Ltd) | HOSPITAL ONLY PRESCRIBING | ||||
Solution for infusion | |||||
Methotrexate (Non-proprietary) | HOSPITAL ONLY PRESCRIBING | ||||
mometasone furoate | FORMULARY PRODUCT | ||||
Liquid | |||||
Elocon (Organon Pharma (UK) Ltd) | NON-FORMULARY | ||||
pimecrolimus | SPECIALIST INITIATED- Primary care to continue with no Shared Care Guidelines |
NICE TA82 |
|||
tacalcitol | NON-FORMULARY | ||||
tacrolimus | SPECIALIST INITIATED- Primary care to continue with no Shared Care Guidelines |
NICE TA82 NICE TA481 NICE TA481 |
|||
TACROLIMUS IN RENAL TRANSPLANTATION
Tacrolimus is HOSPITAL ONLY for use inr enal transplantation |
|||||
TACROLIMUS
Tacrolimus is HOSPITAL ONLY for renal transplantation |
|||||
Modified-release tablet | |||||
Envarsus (Chiesi Ltd) | SPECIALIST INITIATED- Primary care to continue with Shared Care Guidelines | ||||
Modified-release capsule | |||||
Advagraf (Astellas Pharma Ltd) | SPECIALIST INITIATED- Primary care to continue with Shared Care Guidelines | ||||
Solution for infusion | |||||
Prograf (Astellas Pharma Ltd) | HOSPITAL ONLY PRESCRIBING | ||||
tralokinumab | HOSPITAL ONLY PRESCRIBING |
NICE TA814 |
|||
ustekinumab | HOSPITAL ONLY PRESCRIBING |
NICE TA180 NICE TA340 NICE TA456 NICE TA633 |
|||
Solution for injection | |||||
Stelara (Janssen-Cilag Ltd) | HOSPITAL ONLY PRESCRIBING | ||||
Solution for infusion | |||||
Stelara (Janssen-Cilag Ltd) | HOSPITAL ONLY PRESCRIBING | ||||
Skin / Urticaria | |||||
acrivastine | NON-FORMULARY | ||||
alimemazine tartrate | NON-FORMULARY | ||||
Oral solution | |||||
Alimemazine tartrate (Non-proprietary) | NON-FORMULARY | ||||
fexofenadine hydrochloride | FORMULARY PRODUCT | ||||
levocetirizine hydrochloride | NON-FORMULARY | ||||
Oral solution | |||||
Xyzal (UCB Pharma Ltd) | NON-FORMULARY | ||||
loratadine | FORMULARY PRODUCT | ||||
Hayfever OTC
NHS England guidance for CCGs on prescribing of OTC products (Mar-18):
Link to 1-page patient information sheet to support discussions between patients and healthcare professionals. General exceptions listed in guidance include long-term conditions; complex illness; patient group not licensed for OTC product; exceptional circumstances based on clinician’s judgement. See guidance for full list. |
|||||
Oral solution | |||||
Loratadine (Non-proprietary) | FORMULARY PRODUCT | ||||
omalizumab | HOSPITAL ONLY PRESCRIBING |
NICE TA278 NICE TA339 |
|||
Solution for injection | |||||
Xolair (Novartis Pharmaceuticals UK Ltd) | HOSPITAL ONLY PRESCRIBING | ||||
promethazine hydrochloride | FORMULARY PRODUCT | ||||
Oral solution | |||||
Phenergan (Sanofi Consumer Healthcare) | FORMULARY PRODUCT | ||||
Solution for injection | |||||
Phenergan (Sanofi Consumer Healthcare) | HOSPITAL ONLY PRESCRIBING | ||||
Skin / Skin cleansers, antiseptics and desloughing agents | |||||
alcohol | NON-FORMULARY | ||||
Form unstated | |||||
Alcohol (Non-proprietary) | NON-FORMULARY | ||||
chlorhexidine | FORMULARY PRODUCT | ||||
Liquid | |||||
Cepton (Dendron Brands Ltd) | NON-FORMULARY | ||||
Hibi (Molnlycke Health Care Ltd) | FORMULARY PRODUCT | ||||
Hibiscrub (Molnlycke Health Care Ltd) | FORMULARY PRODUCT | ||||
Hydrex (Ecolab Healthcare Division) | FORMULARY PRODUCT | ||||
chlorhexidine gluconate with isopropyl alcohol | |||||
Liquid | |||||
ChloraPrep (Becton, Dickinson UK Ltd) | NON-FORMULARY | ||||
hydrogen peroxide | FORMULARY PRODUCT | ||||
Liquid | |||||
Hydrogen peroxide (Non-proprietary) | FORMULARY PRODUCT | ||||
potassium permanganate | FORMULARY PRODUCT | ||||
Tablet for cutaneous solution | |||||
Potassium permanganate (Non-proprietary) | FORMULARY PRODUCT | ||||
Permitabs (Alliance Pharmaceuticals Ltd) | FORMULARY PRODUCT | ||||
povidone-iodine | FORMULARY PRODUCT | ||||
Eye drops | |||||
Povidone-iodine (Non-proprietary) | HOSPITAL ONLY PRESCRIBING | ||||
Liquid | |||||
Videne (Ecolab Healthcare Division) | FORMULARY PRODUCT | ||||
proflavine | NON-FORMULARY | ||||
Skin / Pruritus | |||||
alimemazine tartrate | NON-FORMULARY | ||||
Oral solution | |||||
Alimemazine tartrate (Non-proprietary) | NON-FORMULARY | ||||
chlorphenamine maleate | FORMULARY PRODUCT | ||||
Oral solution | |||||
Chlorphenamine maleate (Non-proprietary) | FORMULARY PRODUCT | ||||
Allerief (Crescent Pharma Ltd) | NON-FORMULARY | ||||
Piriton (Haleon UK Ltd) | NON-FORMULARY | ||||
Solution for injection | |||||
Chlorphenamine maleate (Non-proprietary) | HOSPITAL ONLY PRESCRIBING | ||||
coal tar with calamine | SPECIALIST INITIATED- Primary care to continue with no Shared Care Guidelines | ||||
crotamiton | FORMULARY PRODUCT | ||||
doxepin | NON-FORMULARY | ||||
hydroxyzine hydrochloride | FORMULARY PRODUCT | ||||
levocetirizine hydrochloride | NON-FORMULARY | ||||
Oral solution | |||||
Xyzal (UCB Pharma Ltd) | NON-FORMULARY | ||||
levomenthol | NON-FORMULARY | ||||
Skin / Bacterial skin infections | |||||
metronidazole | FORMULARY PRODUCT | ||||
mupirocin | FORMULARY PRODUCT | ||||
neomycin sulfate | NON-FORMULARY | ||||
silver sulfadiazine | HOSPITAL ONLY PRESCRIBING | ||||
Skin / Fungal skin infections | |||||
amorolfine | FORMULARY PRODUCT | ||||
benzoic acid with salicylic acid | NON-FORMULARY | ||||
clotrimazole | FORMULARY PRODUCT | ||||
NHSE OTC: Athletes Foot/ Fungal
NHS England guidance for CCGs on prescribing of OTC products (Mar-18):
General exceptions listed in guidance include long-term conditions; complex illness; patient group not licensed for OTC product; exceptional circumstances based on clinician’s judgement. See guidance for full list. |
|||||
Liquid | |||||
Canesten (Bayer Plc) | FORMULARY PRODUCT | ||||
econazole nitrate | NON-FORMULARY | ||||
griseofulvin | NON-FORMULARY | ||||
ketoconazole | FORMULARY PRODUCT | ||||
miconazole | FORMULARY PRODUCT | ||||
Spray | |||||
Daktarin (Johnson & Johnson Ltd) | FORMULARY PRODUCT | ||||
NHSE OTC: Athletes Foot/ Fungal
NHS England guidance for CCGs on prescribing of OTC products (Mar-18):
General exceptions listed in guidance include long-term conditions; complex illness; patient group not licensed for OTC product; exceptional circumstances based on clinician’s judgement. See guidance for full list. |
|||||
terbinafine | FORMULARY PRODUCT | ||||
tioconazole | NON-FORMULARY | ||||
Skin / Parasitic skin infections | |||||
benzyl benzoate | NON-FORMULARY | ||||
dimeticone | NON-FORMULARY | ||||
Liquid | |||||
Hedrin (Thornton & Ross Ltd) | NON-FORMULARY | ||||
Lyclear (Omega Pharma Ltd) | NON-FORMULARY | ||||
Cutaneous spray solution | |||||
Hedrin (Thornton & Ross Ltd) | NON-FORMULARY | ||||
malathion | FORMULARY PRODUCT | ||||
permethrin | FORMULARY PRODUCT | ||||
Liquid | |||||
Lyclear (Omega Pharma Ltd) | NON-FORMULARY | ||||
Skin / Viral skin infections | |||||
aciclovir | FORMULARY PRODUCT | ||||
Oral suspension | |||||
Aciclovir (Non-proprietary) | NON-FORMULARY | ||||
Zovirax (GlaxoSmithKline UK Ltd) | NON-FORMULARY | ||||
Solution for infusion | |||||
Aciclovir (Non-proprietary) | HOSPITAL ONLY PRESCRIBING |